全文获取类型
收费全文 | 373篇 |
免费 | 36篇 |
国内免费 | 7篇 |
专业分类
儿科学 | 50篇 |
妇产科学 | 7篇 |
基础医学 | 53篇 |
口腔科学 | 5篇 |
临床医学 | 36篇 |
内科学 | 94篇 |
皮肤病学 | 18篇 |
神经病学 | 7篇 |
特种医学 | 55篇 |
外科学 | 17篇 |
综合类 | 12篇 |
预防医学 | 15篇 |
药学 | 38篇 |
肿瘤学 | 9篇 |
出版年
2023年 | 1篇 |
2022年 | 4篇 |
2021年 | 7篇 |
2020年 | 2篇 |
2019年 | 7篇 |
2018年 | 3篇 |
2017年 | 5篇 |
2016年 | 10篇 |
2015年 | 8篇 |
2014年 | 7篇 |
2013年 | 8篇 |
2012年 | 16篇 |
2011年 | 16篇 |
2010年 | 7篇 |
2009年 | 14篇 |
2008年 | 7篇 |
2007年 | 17篇 |
2006年 | 10篇 |
2005年 | 17篇 |
2004年 | 13篇 |
2003年 | 9篇 |
2002年 | 16篇 |
2001年 | 10篇 |
2000年 | 10篇 |
1999年 | 11篇 |
1998年 | 11篇 |
1997年 | 5篇 |
1996年 | 11篇 |
1995年 | 10篇 |
1994年 | 16篇 |
1993年 | 13篇 |
1992年 | 9篇 |
1991年 | 7篇 |
1990年 | 4篇 |
1989年 | 11篇 |
1988年 | 17篇 |
1987年 | 15篇 |
1986年 | 9篇 |
1985年 | 8篇 |
1984年 | 3篇 |
1983年 | 6篇 |
1982年 | 3篇 |
1981年 | 9篇 |
1980年 | 5篇 |
1979年 | 1篇 |
1978年 | 3篇 |
1977年 | 2篇 |
1975年 | 3篇 |
排序方式: 共有416条查询结果,搜索用时 15 毫秒
31.
32.
33.
Grimwood K Huang QS Sadleir LG Nix WA Kilpatrick DR Oberste MS Pallansch MA 《Journal of clinical microbiology》2003,41(5):2230-2232
During a community echovirus type 33 outbreak, the virus was detected in the feces and cerebrospinal fluid of a 3-year-old boy with right arm weakness that followed a mild nonspecific febrile illness. This is the first time an association between echovirus type 33 infection and acute flaccid paralysis has been reported. 相似文献
34.
Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies 总被引:7,自引:0,他引:7
Taylor RN Grimwood J Taylor RS McMaster MT Fisher SJ North RA 《American journal of obstetrics and gynecology》2003,188(1):177-182
OBJECTIVE: Complicated pregnancies demonstrate abnormal decidual and placental villous vasculature. We examined maternal concentrations of vascular endothelial growth factor and placental growth factor in normal pregnancies and in pregnancies that were complicated by isolated idiopathic small-for-gestational-age (SGA) newborn infants, preeclampsia alone, or preeclampsia with SGA newborn infants at the time of clinical disease and before the onset of clinical signs. STUDY DESIGN: Serum vascular endothelial growth factor and placental growth factor were measured by enzyme-linked immunosorbent assay in cross-sectional and longitudinal cohorts of pregnant nulliparous women. The results were compared by Wilcoxon tests or a mixed-models method, respectively. RESULTS: In the cross-sectional study, serum placental growth factor was reduced in abnormal pregnancy relative to control subjects (SGA newborn infants, 18 [P =.04]; preeclampsia, 20; or preeclampsia with small- for-gestational-age newborn infants, 11 [P =.0001]) as early as 15 to 19 weeks of gestation in preeclampsia with SGA newborn infants. Vascular endothelial growth factor was <30 pg/mL in all serum specimens from pregnant women. CONCLUSION: We postulate that decreased placental growth factor production results in abnormalities of placental angiogenesis through direct and indirect effects on other vasculotropic growth factors. 相似文献
35.
Vogel AM McKinlay MJ Ashton T Lennon DR Harding JE Pinnock R Graham D Grimwood K Pattemore PK Schousboe M 《Journal of paediatrics and child health》2002,38(4):352-357
OBJECTIVE: To establish the preterm infant hospitalization risks from respiratory syncytial virus (RSV) in New Zealand and the net cost per hospitalization averted by palivizumab. METHODS: The 437 infants born < 32 weeks' gestation in 1997 and treated at five major neonatal units were identified. Subsequent admissions during the next 2 years for bronchiolitis, pneumonia and croup were tracked, and information collected on RSV tests performed. Data on the length of stay and hospital costs were used to calculate the potential net cost per hospitalization averted associated with the use of palivizumab and the number needed to treat (NNT) to prevent one hospitalization. RESULTS: Estimated RSV readmission risk before 1 year corrected age in infants < 32 weeks' gestation discharged home on oxygen, and those " 28 weeks' gestation, or between 29 and 31 weeks' gestation with or without chronic lung disease was 42%, 23%, 19%, 10% and 8%, respectively. The NNT with palivizumab to prevent one hospitalization ranged from six to 26 across subgroups. Mean (range) net cost per hospitalization averted was 60,000 New Zealand dollars ($28,000-$166,700). In no subgroup would prophylaxis result in net cost saving. Prophylaxis for all NZ infants " 28 weeks' gestation would cost approximately $1,090,000 net and prevent 29 hospitalizations annually, being equivalent to $37,000 net per hospitalization averted, with eight infants treated to prevent one hospitalization. Alternative assumptions about cost and efficacy failed to alter these findings. CONCLUSION: If value is placed on preventing morbidity, the priority groups for palivizumab prophylaxis are preterm infants discharged home on oxygen, followed by preterm infants of 28 weeks' gestation or less. 相似文献
36.
Gosling IA Stone PR Grimwood K 《The Australian & New Zealand journal of obstetrics & gynaecology》2002,42(4):363-365
OBJECTIVE: Determine group B streptococcus (GBS) prevention protocols. METHODS: Questionnaire survey of 19 hospitals accounting for 73% of New Zealand births. RESULTS: Prevention policies were reported by 16 (84%) hospitals (bacteriological-screening n = 4, risk-factor determination n = 8, both strategies n = 4). Only five out of 12 (42%) centres using risk-assessment administered antibiotics for all high-risk criteria. Inadequate specimen collection and culture methods meant no hospital maximised culture-based strategies. Nevertheless, hospitals with prevention policies had lower early-onset GBS disease rates (0.46 versus 1.44 per 1,000 births; OR 0.32; (95% CI 0.12, 0.98)). CONCLUSIONS: Prevention strategies can be further improved by hospitals fully implementing nationally agreed guidelines. 相似文献
37.
Fenton BM Paoni SF Grimwood BG Ding I 《International journal of radiation oncology, biology, physics》2003,57(4):1038-1046
PURPOSE: Recent results in the literature have demonstrated that the antiangiogenic agent endostatin can enhance antitumor effects when administered before or during radiotherapy. To better understand the underlying pathophysiologic basis for this radiosensitization, the current study investigated whether short-term endostatin administration is linked to alterations in tumor vascular perfusion and oxygen delivery. METHODS AND MATERIALS: Three daily doses of recombinant endostatin (20 mg/kg) were administered to two murine mammary carcinomas, the highly vascularized MCa-35 and the less vascularized MCa-4. Image analysis techniques were used to quantify (1) total and perfused vascular spacing, and (2) changes in tumor hypoxia as a function of distance from the nearest blood vessel. RESULTS: In MCa-35 tumors, endostatin had no effect on vessel spacing, tumor hypoxia, or tumor growth. In MCa-4 tumors, total and perfused vessel spacings were also unchanged, but tumor growth was inhibited, and tumor hypoxia significantly decreased. These tumors demonstrated an increased vascular functionality suggestive of an increase in the number of intermittently perfused vessels, without corresponding alterations in tumor oxygen consumption rate. CONCLUSIONS: Poorly vascularized, hypoxic mammary carcinomas were much more responsive to short-term endostatin treatment than well-vascularized, more homogeneously oxygenated tumors. Oxygen levels in the responsive tumors were transiently improved after treatment, which could have substantial implications with respect to the therapeutic effectiveness of combining antiangiogenic agents with conventional therapies. 相似文献
38.
39.
40.
Braffman BH; Coleman BG; Ramchandani P; Arger PH; Nodine CF; Dinsmore BJ; Louie A; Betsch SE 《Radiology》1994,190(3):797